Document is current
Any future updates will be listed below
-
Authors
Datki, Zsolt https://orcid.org/0000-0002-2537-4741
Galik-Olah, Zita https://orcid.org/0000-0002-6372-532X
Janosi-Mozes, Emese https://orcid.org/0000-0003-1532-289X
Szegedi, Viktor https://orcid.org/0000-0003-4191-379X
Kalman, Janos https://orcid.org/0000-0001-5319-5639
Hunya, Ákos Gábor https://orcid.org/0000-0002-4547-9284
Fulop, Livia https://orcid.org/0000-0002-8010-0129
Tamano, Haruna
Takeda, Atsushi https://orcid.org/0000-0001-7519-2957
Adlard, Paul A.
Bush, Ashley I. https://orcid.org/0000-0001-8259-9069
- License Information
-
More Information
Article History
Received: 15 October 2019
Revised: 16 May 2020
Accepted: 21 May 2020
First Online: 9 June 2020
Compliance with ethical standards
:
: AIB is a shareholder in Alterity Ltd, Cogstate Ltd, Brighton Biotech LLC, Grunbiotics Pty Ltd, Eucalyptus Pty Ltd, and Mesoblast Ltd. He is a paid consultant for, and has a profit share interest in Collaborative Medicinal Development Pty Ltd.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All procedures performed in studies involving animals were in accordance with the ethical standards of the institution or practice at which the studies were conducted (The University of Szeged; approval number: I-02442/001/2006).
